NA

Naveen Antony

Active Director Director DIN 09763268
DIN 09763268 First appointment Oct 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Naveen Antony

Data last updated:

Naveen Antony is a Director at Primordia Lifesciences Private Limited (since 2022). The company operates in Healthcare. Primordia Lifesciences Private Limited reported revenue of ₹13.4 Lakh (FY 2024).

DIN 09763268
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2022
Oldest Company Age 8 yrs
Largest company Primordia Lifesciences Private Limited · ₹13.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20222018₹13.4 Lakh (FY 2024)Active

Board colleagues of Naveen Antony

Directorship timeline

Open interactive timeline →
Primordia Lifesciences Private Limited
Premium access

Shareholding and investment profile for Naveen Antony

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Antony

Naveen Antony currently holds 1 directorship: Primordia Lifesciences Private Limited (Director, since 12 Oct 2022, revenue ₹13.4 Lakh (FY 2024)).

Naveen Antony was first appointed on 12 Oct 2022 as Director at Primordia Lifesciences Private Limited.

The current boards of Naveen Antony's companies include Anu Yamuna Joseph (Primordia Lifesciences Private Limited), Joe Joseph (Primordia Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available